Cargando…

Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results

SIMPLE SUMMARY: Pulsed-reduced dose rate (PRDR) is a technique used to safely deliver re-irradiation by targeting dividing neoplastic cells while permitting intra-therapy sublethal damage repair in previously irradiated normal tissues. However, treatment-related toxicities are not uniformly reported...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kutuk, Tugce, Tolakanahalli, Ranjini, McAllister, Nicole C., Hall, Matthew D., Tom, Martin C., Rubens, Muni, Appel, Haley, Gutierrez, Alonso N., Odia, Yazmin, Mohler, Alexander, Ahluwalia, Manmeet S., Mehta, Minesh P., Kotecha, Rupesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221236/ https://www.ncbi.nlm.nih.gov/pubmed/35740612 http://dx.doi.org/10.3390/cancers14122946

Ejemplares similares

33. SYSTEMATIC REVIEW AND META-ANALYSIS OF BREAST CANCER BRAIN METASTASIS AND PRIMARY TUMOR RECEPTOR EXPRESSION DISCORDANCE
por: Kotecha, Rupesh, et al.
Publicado: (2020)

OTHR-07. Systematic Review and Meta-analysis of Lung Cancer Brain Metastasis and Primary Tumor PD-L1 Expression Discordance
por: Tonse, Raees, et al.
Publicado: (2021)

Systematic review and meta-analysis of PD-L1 expression discordance between primary tumor and lung cancer brain metastasis
por: Tonse, Raees, et al.
Publicado: (2021)

Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance
por: Tonse, Raees, et al.
Publicado: (2021)

Systematic review and meta-analysis of breast cancer brain metastasis and primary tumor receptor expression discordance
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Zero Setup Margin Mask versus Frame Immobilization during Gamma Knife(®) Icon™ Stereotactic Radiosurgery for Brain Metastases
por: Kutuk, Tugce, et al.
Publicado: (2022)

NEIM-02 CHARACTERIZATION OF LARGE BRAIN METASTASES WITH(18)F-FLUCICLOVINE PET/CT TREATED WITH STAGED STEREOTACTIC RADIOSURGERY (SSRS): INTERIM ANALYSIS OF A PILOT STUDY
por: Rosa, Alonso La, et al.
Publicado: (2023)

Evaluating the intracranial activity of adagrasib
por: Kotecha, Rupesh, et al.
Publicado: (2023)

Dosimetric Impact of Lesion Number, Size, and Volume on Mean Brain Dose with Stereotactic Radiosurgery for Multiple Brain Metastases
por: La Rosa, Alonso, et al.
Publicado: (2023)

Temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade gliomas
por: La Rosa, Alonso, et al.
Publicado: (2023)

Factors associated with unplanned readmissions and costs following resection of brain metastases in the United States
por: Tonse, Raees, et al.
Publicado: (2021)

Regression of Intracranial Meningiomas Following Treatment with Cabozantinib
por: Kotecha, Rupesh, et al.
Publicado: (2021)

SPIN-01 RADIATION THERAPY ALONE VERSUS RADIATION THERAPY PLUS RADIOFREQUENCY ABLATION/VERTEBRAL AUGMENTATION FOR SPINE METASTASIS: TRIAL IN PROGRESS
por: Kotecha, Rupesh, et al.
Publicado: (2022)

Feasibility of Tumor Treating Fields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Single-Center, Real-World Data
por: Kutuk, Tugce, et al.
Publicado: (2022)

Meta-Analysis of Survival and Development of a Prognostic Nomogram for Malignant Pleural Mesothelioma Treated with Systemic Chemotherapy
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Hospitalization rates for complications due to systemic therapy in the United States
por: Saxena, Anshul, et al.
Publicado: (2021)

RONC-08. SURVIVAL IMPACT OF POSTOPERATIVE RADIOTHERAPY TIMING IN PEDIATRIC AND YOUNG ADULT EPENDYMOMA
por: Shah, Sunny, et al.
Publicado: (2020)

Hospitalization rates from radiotherapy complications in the United States
por: Tonse, Raees, et al.
Publicado: (2022)

DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets
por: Ozair, Ahmad, et al.
Publicado: (2023)

Relationship between insurance status and interhospital transfers among cancer patients in the United States
por: Rubens, Muni, et al.
Publicado: (2022)

Recent advances in managing brain metastasis
por: Kotecha, Rupesh, et al.
Publicado: (2018)

Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases
por: Tonse, Raees, et al.
Publicado: (2021)

Erratum to: Stereotactic targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review
por: Odia, Yazmin, et al.
Publicado: (2022)

Surgically targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review
por: Odia, Yazmin, et al.
Publicado: (2022)

Evaluation of the impact of pre-operative stereotactic radiotherapy on the acute changes in histopathologic and immune marker profiles of brain metastases
por: Kotecha, Rupesh, et al.
Publicado: (2022)

Radiation therapy alone versus radiation therapy plus radiofrequency ablation/vertebral augmentation for spine metastasis: study protocol for a randomized controlled trial
por: Kotecha, Rupesh, et al.
Publicado: (2020)

OptImal Gamma kNife lIghTnIng sOlutioN (IGNITION) score to characterize the solution space of the Gamma Knife FIP optimizer for stereotactic radiosurgery
por: Tolakanahalli, Ranjini, et al.
Publicado: (2023)

A study on inter‐planner plan quality variability using a manual planning‐ or Lightning dose optimizer‐approach for single brain lesions treated with the Gamma Knife(®) Icon™
por: Lee, Yongsook C., et al.
Publicado: (2023)

Effect of Postoperative Radiation Therapy Timing on Survival in Pediatric and Young Adult Ependymoma
por: Shah, Sunny, et al.
Publicado: (2021)

Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy(10) for Non-bone Oligometastases
por: Kutuk, Tugce, et al.
Publicado: (2022)

TRLS-01. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS (TTFIELDS) FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
por: Mehta, Minesh, et al.
Publicado: (2019)

CLRM-10 METIS (EF-25): A PIVOTAL, RANDOMIZED CONTROLLED STUDY OF TUMOR TREATING FIELDS IN PATIENTS WITH 1–10 BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
por: Mehta, Minesh, et al.
Publicado: (2022)

30. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
por: Mehta, Minesh P, et al.
Publicado: (2020)

RADI-11. Evaluating the Tissue Effects of Dose-escalated Pre-operative Stereotactic Radiotherapy for Resectable Brain Metastasis
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Update on the Management of Brain Metastasis
por: Singh, Karanvir, et al.
Publicado: (2022)

Editorial: Effects of radiation therapies on brain metastases
por: Kotecha, Rupesh, et al.
Publicado: (2023)

The effect and stability of MVCT images on adaptive TomoTherapy
por: Yadav, Poonam, et al.
Publicado: (2010)

Emerging Evidence on the Effects of Dietary Factors on the Gut Microbiome in Colorectal Cancer
por: Appunni, Sandeep, et al.
Publicado: (2021)

Brain metastasis and treatment
por: Ahluwalia, Manmeet S., et al.
Publicado: (2014)

Fractionated Total Body Irradiation on an Infant Using Tomotherapy
por: Abraham, Usha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ufipandfj7vee0piotu7ggj9hs